Literature DB >> 22476204

Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Alejandro Balestracci1, Sandra Mariel Martin, Ismael Toledo, Caupolican Alvarado, Raquel Eva Wainsztein.   

Abstract

BACKGROUND: Oligoanuric forms of postdiarrheal hemolytic uremic syndrome (D+ HUS) usually have more severe acute stage and higher risk of chronic sequelae than nonoligoanuric forms. During the diarrheal phase, gastrointestinal losses could lead to dehydration with pre-renal injury enhancing the risk of oligoanuric D+ HUS. Furthermore, it had been shown that intravenous volume expansion during the prodromal phase could decrease the frequency of oligoanuric renal failure. Thus, we performed this retrospective study to determine whether dehydration on admission is associated with increased need for dialysis in D+ HUS patients. CASE-DIAGNOSIS/TREATMENT: Data from 137 children was reviewed, which were divided into two groups according to their hydration status at admission: normohydrated (n = 86) and dehydrated (n = 51). Laboratory parameters of the dehydrated patients reflected expected deteriorations (higher urea, higher hematocrit and lower sodium, bicarbonate, and pH) than normohydrated ones. Likewise, the dehydrated group had a higher rate of vomiting and need for dialysis (70.6 versus 40.7 %, p = 0.0007).
CONCLUSIONS: Our data suggests that dehydration at hospital admission might represent a concomitant factor aggravating the intrinsic renal disease in D+ HUS patients increasing the need for dialysis. Therefore, the early recognition of patients at risk of D+ HUS is encouraged to guarantee a well-hydrated status.

Entities:  

Mesh:

Year:  2012        PMID: 22476204     DOI: 10.1007/s00467-012-2158-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children.

Authors:  Ricardo C Rahman; Carlos J Cobeñas; Ricardo Drut; Oscar R Amoreo; Javier D Ruscasso; Ana P Spizzirri; Angela Del C Suarez; Javier H Zalba; Celia Ferrari; Marcela C Gatti
Journal:  Pediatr Nephrol       Date:  2011-08-02       Impact factor: 3.714

3.  Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features.

Authors:  F D Spizzirri; R C Rahman; N Bibiloni; J D Ruscasso; O R Amoreo
Journal:  Pediatr Nephrol       Date:  1997-04       Impact factor: 3.714

4.  Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.

Authors:  M G Caletti; G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1996-12       Impact factor: 3.714

Review 5.  Clinical practice. Today's understanding of the haemolytic uraemic syndrome.

Authors:  Johanna Scheiring; Alejandra Rosales; Lothar Bernd Zimmerhackl
Journal:  Eur J Pediatr       Date:  2009-08-26       Impact factor: 3.183

6.  Changes in the postenteropathic form of the hemolytic uremic syndrome in children.

Authors:  N A Coad; T Marshall; B Rowe; C M Taylor
Journal:  Clin Nephrol       Date:  1991-01       Impact factor: 0.975

Review 7.  Management of diarrhea-associated hemolytic uremic syndrome in children.

Authors:  Kazumoto Iijima; Ichiro Kamioka; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

8.  Hemolytic uremic syndrome in families-an Argentinian experience.

Authors:  L E Voyer; R E Wainsztein; B E Quadri; S E Corti
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

Review 9.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

Review 10.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Johanna Scheiring; Sharon P Andreoli; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more
  24 in total

1.  Shifting the Paradigm in Hemolytic Uremic Syndrome.

Authors:  David N Cornfield
Journal:  Pediatrics       Date:  2015-12-07       Impact factor: 7.124

2.  Hemoconcentration in hemolytic uremic syndrome: time to review the standard case definition?

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo
Journal:  Pediatr Nephrol       Date:  2014-10-26       Impact factor: 3.714

3.  A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.

Authors:  Gianluigi Ardissino; Francesca Tel; Sara Testa; Fabio Paglialonga; Selena Longhi; Laura Martelli; Silvia Consolo; Damiano Picicco; Antonella Dodaro; Laura Daprai; Rosaria Colombo; Milena Arghittu; Michela Perrone; Giovanna Chidini; Stefano Scalia Catenacci; Isabella Cropanese; Dario Consonni
Journal:  Eur J Pediatr       Date:  2018-08-10       Impact factor: 3.183

Review 4.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

5.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

6.  C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Luciana Meni Bataglia; Ismael Toledo; Laura Beaudoin; Caupolican Alvarado
Journal:  Pediatr Nephrol       Date:  2019-09-02       Impact factor: 3.714

7.  Comment to "Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome" by Keenswijk et al. Eur J Pediatr 2017; 176(3): 355-360.

Authors:  Gianluigi Ardissino; Francesca Tel; Damiano Picicco; Antonella Dodaro; Laura Daprai; Silvia Consolo; Sara Testa; Fabio Paglialonga; Dario Consonni
Journal:  Eur J Pediatr       Date:  2017-08-19       Impact factor: 3.183

8.  Blood urea nitrogen to serum creatinine ratio as a prognostic factor in diarrhea-associated hemolytic uremic syndrome: a validation study.

Authors:  Alejandro Balestracci; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Caupolican Alvarado
Journal:  Eur J Pediatr       Date:  2017-08-23       Impact factor: 3.183

9.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

Review 10.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.